胃癌靶向治疗的研究进展

Multidisciplinary treatment of liver metastases of gastric cancer

The liver is the main target organ of the metastasis for gastric cancer. In cases of liver metastases of gastric cancer, the clinical effects of many treatments are not ideal. The morbidity of liver metastases of gastric cancer is high, which is one of the leading causes of death in gastric cancer patients. Currently, there have been no standardized treatment strategies. In recent years, the use of multidisciplinary treatment can prolong the survival of gastric cancer patients with liver metastases. Multidisciplinary treatment, which is based on individual patient's condition and combines surgery, chemotherapy, radiofrequency ablation, transarterial chemoembolization and targeted therapy, may improve the outcomes radically.

Impact of traditional Chinese medicine combined with TCF regimen chemotherapy on quality of life in patients with advanced gastric cancer

AIM: To evaluate the impact of Jianpi Tongluo formula combined with taxol + calcium folinate + 5-fluorouracil (TCF) regimen chemotherapy on quality of life (QOL) in patients with advanced gastric cancer.

METHODS: Ninety-eight patients with advanced gastric cancer were divided into either a control group (49 cases) or a research group (49 cases). The control group was treated with TCF alone, and the research group was treated with Jianpi Tongluo formula combined with TCF. Clinical effects were compared for the two groups.

RESULTS: The total effective rate for the research group was higher than that for the control group (81.63% vs 61.22%, P < 0.05). The scores of physical functioning, role function, cognitive function, emotional functioning, and social function for the research group post treatment were significantly higher than those prior treatment (88.56 ± 11.24 vs 78.33 ± 13.24, 70.89 ± 12.03 vs 53.78 ± 14.67, 74.56 ± 11.24 vs 59.33 ± 13.24, 71.89 ± 12.03 vs 58.78 ± 14.67, 70.78 ± 14.86 vs 62.74 ± 15.46, P < 0.05 for all). The scores of role function, emotional functioning, and social function for the control group post treatment were significantly higher than those prior treatment (61.88 ± 12.02 vs 53.75 ± 13.80, 65.88 ± 14.00 vs 58.75 ± 13.80, 69.94 ± 14.89 vs 61.73 ± 13.85, P < 0.05 for all). The scores of physical functioning, role function, cognitive function, and emotional functioning for the research group post treatment were significantly higher than those for the control group (88.56 ± 11.24 vs 80.53 ± 13.55, 70.89 ± 12.03 vs 61.88 ± 12.02, 74.56 ± 11.24 vs 62.53 ± 13.55, 71.89 ± 12.03 vs 65.88 ± 14.00, P < 0.05 for all).

CONCLUSION: Jianpi Tongluo formula combined with TCF regimen chemotherapy has a higher effective rate in patients with advanced gastric cancer than chemotherapy alone, and it can increase the QOL.